300677 英科医疗
2026/03 - 三个月
人民幣(K¥)
与去年同期
比较
2025/12
人民幣(K¥)
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
营业总收入2,887,03415.76%9,925,8199,523,3176,918,7246,613,814
减:营业总成本2,673,51020.00%9,433,9558,106,2026,753,5606,051,332
    其中:营业成本2,119,98712.09%7,531,5567,272,3485,971,0235,745,717
               财务费用202,066-1,758.82%416,528(436,625)(306,436)(627,253)
               资产减值损失37,979-4,084.72%(31,422)(109,053)(5,349)(44,038)
公允价值变动收益(257,351)-455.26%318,499279,767175,56759,670
投资收益35,39045.84%379,72163,17787,44683,271
    其中:对联营企业和合营企业的投资收益------------
营业利润40,279-89.85%1,230,1711,676,824438,990707,184
利润总额46,348-88.32%1,229,7401,608,918442,818704,414
减:所得税费用35,7570.86%182,553117,22954,75365,071
净利润10,591-97.07%1,047,1871,491,689388,065639,343
减:非控股权益560-93.52%36,48726,2135,06710,273
股东净利润10,031-97.16%1,010,7001,465,476382,998629,070

市场价值指针
每股收益 (元) *0.020-96.36%1.5802.2600.5800.950
每股派息 (元) *----0.1500.1500.0800.100
每股净资产 (元) *27.8731.44%27.86126.93324.43423.965
审计意见 #----标准的无保留意见标准的无保留意见标准的无保留意见
回页顶
备注: *未调整数据
#只提供简体内容